Section Arrow
Quote
CNTA.NASDAQ
- Centessa Pharmaceuticals plc
Quotes are at least 15-min delayed:2025/09/05 17:04 EDT
After Hours
Last
 15.42
-0.31 (-1.97%)
Bid
15.4
Ask
15.88
High 15.73 
Low 15.42 
Volume 13976 
Regular Hours
Last
 15.73
-0.06 (-0.38%)
Day High 
16.13 
Prev. Close
15.79 
1-M High
18.14 
Volume 
495.97K 
Bid
15.4
Ask
15.88
Day Low
15.68 
Open
15.87 
1-M Low
15.01 
Market Cap 
2.12B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 16.73 
20-SMA 17.01 
50-SMA 15.84 
52-W High 19.09 
52-W Low 9.6 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.85/-1.74
Enterprise Value
2.23B
Balance Sheet
Book Value Per Share
2.57
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
GNPXGenprex0.2295+0.0738+47.40%0.18PE
After Hours 0.1973 -0.0322 -14.03%
ADAPAdaptimmune Therapeutics plc0.041-0.01-19.61%-- 
After Hours 0.0422 +0.0012 +2.93%
NUVBNuvation Bio3.9+0.48+14.04%-- 
After Hours 3.89 -0.01 -0.26%
KLTOKlotho Neurosciences Inc0.4851-0.0099-2.00%-- 
After Hours 0.479 -0.0061 -1.26%
IOVAIovance Biotherapeutics2.49+0.29+13.18%-- 
After Hours 2.47 -0.02 -0.80%
Quotes are at least 15-min delayed：2025/09/05 17:04 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.